Search earnings tickers

LLY

2025Q1BMO

Eli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-05-01 · Fiscal end 2025-03-31 · Features as of 2025-04-30

← Earnings history

Street

Consensus EPS3.46

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.2%

IV front—

P/C full—

P/C front—

Features as of2025-04-30

Run-up

Close—

Ret 5d+8.4%

Ret 10d+18.7%

Ret 20d+11.6%

Ret 30d+9.3%

Print

Actual EPS

3.34Miss

Estimated EPS3.46

Actual revenue

12.7B

Surprise %-3.5%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction-5.9%

Implied vs actual

Implied 2.2%Actual 6.1%

Gap reaction-6.1%

Day result-11.7%

Next-day upNo

Realized / IV2.72×

Post tape

Post 5d-5.4%

Post 10d-7.7%

Post volume12.6M

Vol ×10d3.16×

Vol ×20d3.10×

Post range7.0%

LLY

Pre-Earnings Data